Thomas Needham
InvestorManaging Director at Broadview Ventures
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Thomas
Sign up to see every warm intro you have to Thomas
- Paths you didn't know you had: your email and LinkedIn already hold routes to Thomas. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Managing Director at Broadview Ventures leading the Biopharmaceuticals practice and overseeing investment strategy and portfolio management, and also Managing Director of Longview Ventures. He has about 30 years of experience in life science venture capital and executive roles, previously CBO at Merrimack Pharmaceuticals and SVP of Business Development at C4 Therapeutics, with earlier roles at Synthesis Capital and Advent International.
Contact· self-published, not guessed
Investments
Investor
Per curated public sources.
Colleagues at Broadview Ventures
Network5
Investors connected to Thomas in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Thomas Needham?
- Managing Director at Broadview Ventures leading the Biopharmaceuticals practice and overseeing investment strategy and portfolio management, and also Managing Director of Longview Ventures. He has about 30 years of experience in life science venture capital and executive roles, previously CBO at Merrimack Pharmaceuticals and SVP of Business Development at C4 Therapeutics, with earlier roles at Synthesis Capital and Advent International.
- Where does Thomas Needham work?
- Thomas Needham is Managing Director at Broadview Ventures.
- What check size does Thomas Needham write?
- Thomas Needham typically writes checks of $100K – $5M.
- What companies has Thomas Needham invested in?
- Investments tracked here include Isomab.
About this profile. Compiled from public sources — Broadview Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights










